Literature DB >> 21475522

Genetic background of psoriasis.

Hani A Alshobaili, Muhammad Shahzad, Abdullah Al-Marshood, Alsayed Khalil, Ahmad Settin, Issam Barrimah.   

Abstract

Psoriasis is a chronic inflammatory dermatosis that contributes to approximately 1-5% of all skin disorders in Saudi Arabia. The genetic basis of psoriasis is supported by family based investigations; population based epidemiological studies, association studies with human leucocyte antigens (HLAs), genome-wide linkage scans, and candidate gene studies within and outside the major histocompatibility complex. Psoriasis represents a complex disease at the cellular, genomic and genetic levels, with infiltration of many types of leukocytes into the skin, altered growth and differentiation of skin-resident cells, and altered expression of more than 1,300 genes in psoriatic lesions. It is also apparent that there is considerable overlap between the molecular pathways that are involved in psoriasis and those that lead to other inflammatory or autoimmune diseases in humans. In this review article, we describe the immune-genetic basis of psoriasis, the molecular pathways of pathogenic inflammation and the potential role of the genes that confer increased susceptibility to psoriasis.

Entities:  

Keywords:  Autoimmune; Genetics; HLA; Psoriasis

Year:  2010        PMID: 21475522      PMCID: PMC3068801     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  43 in total

Review 1.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors:  Brian J Nickoloff; Frank O Nestle
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  The CX3CL1-CX3CR1 system and psoriasis.

Authors:  Darren Plant; Helen S Young; Rachel E B Watson; Jane Worthington; Christopher E M Griffiths
Journal:  Exp Dermatol       Date:  2006-11       Impact factor: 3.960

3.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q.

Authors:  J Tomfohrde; A Silverman; R Barnes; M A Fernandez-Vina; M Young; D Lory; L Morris; K D Wuepper; P Stastny; A Menter
Journal:  Science       Date:  1994-05-20       Impact factor: 47.728

4.  Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis.

Authors:  B D Hardas; X Zhao; J Zhang; X Longqing; S Stoll; J T Elder
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

5.  Excessive paternal transmission in psoriatic arthritis.

Authors:  P Rahman; D D Gladman; C T Schentag; A Petronis
Journal:  Arthritis Rheum       Date:  1999-06

6.  Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

Authors:  Toshihiro Nanki; Toshio Imai; Kenji Nagasaka; Yasuyo Urasaki; Yoshinori Nonomura; Ken Taniguchi; Kenji Hayashida; Jun Hasegawa; Osamu Yoshie; Nobuyuki Miyasaka
Journal:  Arthritis Rheum       Date:  2002-11

7.  Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis.

Authors:  R C Trembath; R L Clough; J L Rosbotham; A B Jones; R D Camp; A Frodsham; J Browne; R Barber; J Terwilliger; G M Lathrop; J N Barker
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

8.  Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.

Authors:  Takeshi Echigo; Minoru Hasegawa; Yuka Shimada; Kazuhiko Takehara; Shinichi Sato
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

9.  Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice.

Authors:  W H Boehncke; W Sterry; A Hainzl; W Scheffold; R Kaufmann
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 10.  Epidemiology and the genetics of psoriasis.

Authors:  J T Elder; R P Nair; J J Voorhees
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

View more
  10 in total

1.  Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline.

Authors:  Audrey Bui; Jared Liu; Julie Hong; Edward Hadeler; Megan Mosca; Nicholas Brownstone; Wilson Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2021-06-21

2.  Leukocyte mitochondrial DNA copy number is a potential non-invasive biomarker for psoriasis.

Authors:  Materah Salem Alwehaidah; Suad AlFadhli; Ghada Al-Kafaji
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

Review 3.  Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review.

Authors:  Nupur U Patel; Kayla Felix; Danielle Reimer; Steven R Feldman
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-09-29

4.  The Use of Metrics in Daily Practice and the Perception of Psoriasis-Associated Comorbidities: Discrepancies Between Research and Real-World.

Authors:  Tom Hillary; Jo Lambert
Journal:  Psoriasis (Auckl)       Date:  2021-12-21

5.  Genital Psoriasis: A Prospective, Observational, Single-Centre Study on Prevalence, Clinical Features, Risk Factors, and Its Impact on Quality of Life and Sexual Health.

Authors:  Ooi Shin Yi; Khor Yek Huan; Loo Chai Har; Norazlima Mohd Ali; Tan Wooi Chiang
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

6.  The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) R620W Functional Polymorphism in Psoriasis.

Authors:  Ghaleb Bin Huraib; Fahad Al Harthi; Misbahul Arfin; Sadaf Rizvi; Abdulrahaman Al-Asmari
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2018-01-11

7.  Assessment of Gap Junction Protein Beta-2 rs3751385 Gene Polymorphism in Psoriasis Vulgaris.

Authors:  Elli-Anna Stylianaki; Anthony Karpouzis; Gregory Tripsianis; Stavroula Veletza
Journal:  J Clin Med Res       Date:  2019-09-01

Review 8.  Experimental Pharmacological Management of Psoriasis.

Authors:  Elena Campione; Terenzio Cosio; Monia Di Prete; Caterina Lanna; Annunziata Dattola; Luca Bianchi
Journal:  J Exp Pharmacol       Date:  2021-07-26

Review 9.  Nanodelivery Strategies for Skin Diseases with Barrier Impairment: Focusing on Ceramides and Glucocorticoids.

Authors:  Cíntia Almeida; Patrícia Filipe; Catarina Rosado; Catarina Pereira-Leite
Journal:  Nanomaterials (Basel)       Date:  2022-01-15       Impact factor: 5.076

10.  Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis.

Authors:  Tom Hillary; Jolien Clijmans; Séverine Vermeire; Jo Lambert; Marjan Garmyn; Maya Imbrechts; Thomas Vanassche
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.